Capstone Investment Advisors LLC Purchases 6,773 Shares of Itron, Inc. (NASDAQ:ITRI)

Capstone Investment Advisors LLC increased its holdings in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 251.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,469 shares of the scientific and technical instruments company's stock after acquiring an additional 6,773 shares during the quarter. Capstone Investment Advisors LLC's holdings in Itron were worth $1,028,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in ITRI. Captrust Financial Advisors lifted its holdings in shares of Itron by 6.3% during the 4th quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company's stock worth $233,000 after acquiring an additional 128 shares during the period. Balyasny Asset Management L.P. grew its stake in shares of Itron by 19.2% in the fourth quarter. Balyasny Asset Management L.P. now owns 214,993 shares of the scientific and technical instruments company's stock worth $23,344,000 after purchasing an additional 34,623 shares during the last quarter. Bayesian Capital Management LP increased its stake in shares of Itron by 18.1% in the fourth quarter. Bayesian Capital Management LP now owns 11,100 shares of the scientific and technical instruments company's stock valued at $1,205,000 after buying an additional 1,700 shares during the period. Algert Global LLC raised its stake in Itron by 16.5% during the fourth quarter. Algert Global LLC now owns 180,585 shares of the scientific and technical instruments company's stock worth $19,608,000 after buying an additional 25,540 shares during the last quarter. Finally, Gallagher Fiduciary Advisors LLC grew its position in shares of Itron by 18.0% during the 4th quarter. Gallagher Fiduciary Advisors LLC now owns 5,417 shares of the scientific and technical instruments company's stock worth $588,000 after buying an additional 826 shares during the period. 96.19% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Piper Sandler cut their price target on Itron from $124.00 to $121.00 and set a "neutral" rating on the stock in a report on Monday, May 5th. Guggenheim reiterated a "buy" rating and issued a $133.00 price objective on shares of Itron in a research note on Thursday, April 17th. Canaccord Genuity Group lifted their price objective on shares of Itron from $130.00 to $132.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Oppenheimer increased their price target on Itron from $124.00 to $131.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 26th. Finally, StockNews.com cut shares of Itron from a "strong-buy" rating to a "buy" rating in a report on Saturday, March 1st. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, Itron presently has a consensus rating of "Moderate Buy" and a consensus target price of $127.36.

Insider Buying and Selling at Itron

In other Itron news, SVP Christopher E. Ware sold 648 shares of the company's stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $92.90, for a total transaction of $60,199.20. Following the sale, the senior vice president now directly owns 20,326 shares in the company, valued at $1,888,285.40. This represents a 3.09 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Mary C. Hemmingsen sold 5,150 shares of the company's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $108.70, for a total transaction of $559,805.00. Following the transaction, the director now owns 952 shares in the company, valued at $103,482.40. The trade was a 84.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 9,187 shares of company stock worth $945,620. 1.45% of the stock is owned by corporate insiders.

Itron Trading Up 0.5 %

ITRI stock traded up $0.51 during trading on Friday, hitting $108.38. 307,833 shares of the company traded hands, compared to its average volume of 568,369. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.83 and a current ratio of 3.36. Itron, Inc. has a 1 year low of $90.11 and a 1 year high of $124.90. The firm has a market capitalization of $4.94 billion, a PE ratio of 22.21, a P/E/G ratio of 0.81 and a beta of 1.31. The company has a 50-day moving average of $104.39 and a 200-day moving average of $107.60.

Itron (NASDAQ:ITRI - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The scientific and technical instruments company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.22. Itron had a net margin of 9.37% and a return on equity of 19.03%. The business had revenue of $607.15 million for the quarter, compared to analysts' expectations of $608.86 million. During the same quarter in the previous year, the business posted $1.24 earnings per share. The firm's revenue for the quarter was up .6% compared to the same quarter last year. Analysts predict that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.

Itron Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.